Jones Financial Companies Lllp Grows Stock Holdings in Inspire Medical Systems, Inc. (NYSE:INSP)

Jones Financial Companies Lllp lifted its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 11.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 2,075 shares of the company’s stock after purchasing an additional 210 shares during the period. Jones Financial Companies Lllp’s holdings in Inspire Medical Systems were worth $385,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of INSP. State Street Corp grew its stake in shares of Inspire Medical Systems by 78.0% in the 3rd quarter. State Street Corp now owns 1,049,784 shares of the company’s stock valued at $221,557,000 after buying an additional 459,990 shares during the period. TimesSquare Capital Management LLC acquired a new position in Inspire Medical Systems during the 4th quarter worth about $80,419,000. Point72 Asset Management L.P. boosted its holdings in Inspire Medical Systems by 954.4% during the 3rd quarter. Point72 Asset Management L.P. now owns 319,364 shares of the company’s stock valued at $67,402,000 after acquiring an additional 289,075 shares during the period. Riverbridge Partners LLC acquired a new position in Inspire Medical Systems in the 4th quarter valued at about $26,342,000. Finally, Principal Financial Group Inc. increased its stake in Inspire Medical Systems by 3,812.6% during the third quarter. Principal Financial Group Inc. now owns 141,089 shares of the company’s stock worth $29,777,000 after purchasing an additional 137,483 shares during the period. Institutional investors and hedge funds own 94.91% of the company’s stock.

Inspire Medical Systems Stock Performance

Shares of NYSE INSP opened at $172.60 on Wednesday. The firm has a market capitalization of $5.12 billion, a P/E ratio of 99.77, a PEG ratio of 2.86 and a beta of 1.48. Inspire Medical Systems, Inc. has a one year low of $123.00 and a one year high of $257.40. The company’s fifty day moving average is $186.71 and its two-hundred day moving average is $192.61.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings results on Monday, February 10th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. On average, sell-side analysts forecast that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Insider Activity

In other Inspire Medical Systems news, CTO John Rondoni sold 583 shares of the stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total transaction of $99,395.67. Following the sale, the chief technology officer now owns 10,424 shares in the company, valued at approximately $1,777,187.76. This represents a 5.30 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Randy Ban sold 25,584 shares of the business’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $183.50, for a total transaction of $4,694,664.00. Following the completion of the transaction, the insider now directly owns 7,259 shares of the company’s stock, valued at $1,332,026.50. The trade was a 77.90 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 26,225 shares of company stock worth $4,806,530 over the last 90 days. 4.10% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

INSP has been the subject of several research reports. Wells Fargo & Company dropped their price target on shares of Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating for the company in a research note on Tuesday, February 11th. KeyCorp restated an “overweight” rating and issued a $234.00 price target (down from $236.00) on shares of Inspire Medical Systems in a research note on Friday, January 24th. Truist Financial lowered their price target on Inspire Medical Systems from $250.00 to $235.00 and set a “buy” rating for the company in a report on Tuesday, February 11th. Morgan Stanley cut their price target on Inspire Medical Systems from $230.00 to $220.00 and set an “overweight” rating on the stock in a research report on Tuesday, February 11th. Finally, Stifel Nicolaus lowered their price objective on shares of Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating on the stock in a research report on Tuesday, January 21st. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, Inspire Medical Systems currently has a consensus rating of “Moderate Buy” and an average target price of $228.82.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.